Article List

WPRIM Management System> DCMS> Journal of Clinical Hepatology> 2023> 39> 11

Volume: 39 Issue: 11

1. Hepatitis E： From behind the scenes to the front stage	Page:2521—2523
2. Advances in the prevention and treatment of the high-risk population for hepatitis E	Page:2524—2529
3. The mechanism of the severe exacerbation and chronicity of hepatitis E virus infection	Page:2530—2537
4. Research advances in the interspecies transmission of hepatitis E virus	Page:2538—2542
5. Guidelines for integrated traditional Chinese and Western medicine diagnosis and treatment of liver cirrhosis	Page:2543—2549
6. Expert consensus on day-case laparoscopic cholecystectomy	Page:2550—2557
7. Key points of EASL Clinical Practice Guidelines on hepatitis delta virus （2023）	Page:2558—2563
8. An excerpt of AASLD practice guidance on the use of TIPS， variceal embolization， and retrograde transvenous obliteration in the management of variceal hemorrhage in 2023	Page:2564—2568
9. A brief introduction of Evidence-based clinical practice guidelines for cholelithiasis 2021 by the Japanese Society of Gastroenterology	Page:2569—2574
10. Trend and prediction of the disease burden of acute hepatitis B in China	Page:2575—2579
11. Value of albumin-related ratios in predicting the risk of death in patients with hepatitis B virus-related acute-on-chronic liver failure	Page:2580—2587
12. ZJU index and the risk of nonalcoholic fatty liver disease in the Uygur population in the rural area of Xinjiang Uygur Autonomous Region： A cohort study	Page:2588—2595
13. Value of serum complement C3 in the diagnosis of liver fibrosis associated with primary biliary cholangitis	Page:2596—2606
14. Diagnostic efficacy of alpha-fetoprotein and alpha-fetoprotein L3% in hepatitis B virus-related early-stage hepatocellular carcinoma	Page:2607—2613
15. Value of fibrosis-4 combined with prognostic nutritional index in predicting recurrence and survival time after radiofrequency ablation for early-stage hepatocellular carcinoma	Page:2614—2622
16. Effect of lysophosphatidic acid on hepatoma cells and related mechanism	Page:2623—2628
17. The influence of diagnostic criteria of different guidelines on short-term prognosis of artificial liver therapy for acute-on-chronic liver failure	Page:2629—2634
18. Value of MELD 3.0， MELD， and MELD-Na scores in assessing the short-term prognosis of patients with acute-on-chronic liver failure： A comparative study	Page:2635—2642
19. Effect and mechanism of safranal in a mouse model of sepsis-related liver injury induced by lipopolysaccharide	Page:2643—2650
20. Clinical features of portal biliopathy	Page:2651—2656
21. Efficacy and safety of stereotactic body radiation therapy in treatment of patients with unresectable cholangiocarcinoma	Page:2657—2662
22. Transcatheter closure of rare type Ⅱ Abernethy malformation with pulmonary hypertension in children： A case report	Page:2663—2667
23. Exploration and practice of the detoxicating， stasis-resolving， and Yang-warming method in reconstructing immune balance in hepatitis B virus-related liver failure	Page:2668—2673
24. Haematological diseases associated with Hepatitis E virus infection	Page:2674—2681
25. Bidirectional relationship between nonalcoholic fatty liver disease and sarcopenia： New insights and perspectives	Page:2682—2688
26. Research advances in noninvasive diagnosis of liver fibrosis in autoimmune liver diseases	Page:2689—2696
27. Neoadjuvant therapy for hepatocellular carcinoma： Current situation and prospects	Page:2697—2704
28. Predictive indicators for the efficacy of targeted therapy/immunotherapy for hepatocellular carcinoma	Page:2705—2709
29. Gut-liver axis： Intestinal microbial homeostasis and hepatocellular carcinoma	Page:2710—2717
30. Current research status of traditional Chinese medicine in the prevention and treatment of hepatocellular carcinoma by regulating the JAK/STAT signaling pathway	Page:2718—2729
31. The physiological and pathological role of amyloid protein in the liver	Page:2730—2737
32. Advances in the diagnosis and treatment of gallbladder carcinoma	Page:2738—2744